Resultados de la búsqueda 231-240 of 14041 for Metabolic alkalosis

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  6. The world's best hospital - Mayo Clinic

    Mayo Clinic is the No. 1 hospital in the world., with campuses in Arizona, Florida, and Minnesota.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  8. Trastorno por consumo de alcohol

    El componente genético de la aparición y el tratamiento de la adicción al alcohol, a las drogas y otras adicciones; Tratamiento para la adicción, como los ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...